Class Action suit accuses AbbVie of unfair pricing

A class action lawsuit filed this week in Chicago alleges the North Chicago-based pharmaceutical company AbbVie Inc. fraudulently inflated the cost of the highest-grossing drug in the world, Humira, by 470% over the last two decades.

Related posts